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Background: aortic aneurysm is a rare but life-threatening cardiovascular complication in patients with systemic lupus
erythematosus (SLE). The purpose of this study was to clarify the characteristic clinical features and the pathological
mechanism of aneurysmal formation in these patients.
Methods: among 429 patients operated on for abdominal aortic aneurysm (AAA) during the past 10 years, five cases
with SLE were treated surgically. Their clinical data were reviewed, and the resected aneurysmal wall of the five patients
was also examined histologically.
Results: the mean age of the patients with SLE was 55 years, which was statistically younger than that of the other
patients (mean 77 years, s.d. 7.9, p<0.05). They had received long-term corticosteroid therapy for the treatment of SLE
for a mean of 23 years. Histologically, destruction of the medial elastic lamina was characteristic. Four patients had no
complications in the postoperative follow-up period (mean 4 years), while the remaining patient died of rupture of a
dissecting aneurysm two years after operation.
Conclusion: prolonged steroid therapy may play a major role in accelerating atherosclerosis, which can result in aortic
aneurysmal enlargement, possibly together with primary aortic wall involvement and/or vasculitic damage in patients
with SLE.
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Introduction recently, only a total of 16 cases of AA in patients with
SLE have been reported hitherto, and little is known
SLE is a chronic systemic inflammatory disease as- about this complication. This report deals with five
cases of AAA in patients with SLE treated surgicallysociated with the production of various autoantibodies
and involvement of multiple organs. This autoimmune at our institution during a 10-year period. Based on
our experience and a review of the reported cases, wecondition has also been known to affect the cardio-
vascular system; mainly as a pancarditis involving investigated the characteristic clinical features and the
mechanism of aneurysmal formation in these patients.the pericardium, myocardium,1–3 endocardium4 and
coronary arteries.4–6 Because of the prolonged survival
due to corticosteroid treatment and advances in diag-
Patients and Methodsnostic modalities, the cardiovascular manifestations of
SLE have become more apparent, and several recent
Between January 1989 and December 1998, 429 patientsreports have indicated increasing cardiovascular mor-
with AAA were operated on in our institution. Amongbidity and mortality in patients with SLE.1–6
them, five cases were associated with SLE (1.2%:Aortic aneurysm (AA) is one of the life-threatening
5/429).cardiovascular complications in patients with SLE.
Although the number of cases has been increasing
Case 1
* Please address all correspondence to: N. Ohara, Division of Vas-
cular Surgery, Department of Surgery, Faculty of Medicine, The A 52-year-old woman was admitted because of dys-
University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, phasia. She had developed a butterfly-rash and fever
Japan. at the age of 32 and had taken corticosteroid for 16† Present address: Division of Vascular Surgery, Department of
Surgery, Saitama Medical School, Japan. years (average 3.5 mg/day) after SLE had been
1078–5884/00/030288+06 $35.00/0 Ó 2000 Harcourt Publishers Ltd.
Aortic Aneurysm with Systemic Lupus Erythematosus 289
diagnosed. She had reduced complement levels and Case 5
proteinuria. Anti-double-strand DNA antibody and
anti-nuclear antibody were both positive. The an- A 34-year-old man was admitted because of bacterial
pneumonia. He had been diagnosed with SLE at thegiogram demonstrated a descending AA and another
infrarenal AAA, which were operated on in two stages. age of 13 because of butterfly-rash, fever and pro-
teinuria with positive anti-double-strand DNA anti-The postoperative course was uneventful, but 2 years
later she died suddenly during admission for the body and anti-nuclear antibody, and had taken
corticosteroid for 21 years (average 4.1 mg/day). Thetreatment of a urinary tract infection. Autopsy revealed
dissection of the ascending aorta with pericardial tam- angiogram demonstrated a low thoracoabdominal and
an infrarenal abdominal aortic aneurysm (Fig. 1). Theseponade, which was the cause of death. The whole
length of the aorta showed striking atherosclerotic were repaired in one stage with reconstruction of
the coeliac artery and superior mesenteric artery. Hechange for her age.
recovered uneventfully.
All of the five patients fulfilled the diagnostic criteria
for SLE, and the disease activity was in remission
Case 2 owing to the corticosteroid therapy at the time of
surgical procedures for aortic aneurysms. None of
A 73-year-old man presented with a pulsating mass them had previously taken any other therapy, e.g.
in his abdomen. He had developed proteinuria, optic immunosuppressive agents. The medical records were
hyperaesthesia and arthritis of both shoulders at the reviewed retrospectively to determine the following
age of 72 and had been treated with steroid therapy factors: age at initial operation, sex, location and type
for one year after the diagnosis of SLE (average 2.5 mg/ of aneurysm, duration of steroid therapy for SLE,
day). Anti-nuclear antibody was positive. He under- survival and periods of follow-up after operation. The
went uneventful replacement of the infrarenal AAA. location and type of aneurysms were determined by
preoperative angiography or computed tomography.
The resected aortic aneurysmal wall of the five patients
with SLE was examined histologically. Comparison of
Case 3 the clinical records was performed by Mann–Whitney
U-test using Statistical Application System software
A 75-year-old woman was admitted for right inguinal (SAS Institute, Cary, NC, U.S.A.). A p-value less than
herniorrhaphy. She had developed proteinuria, but- 0.05 was considered significant.
terfly-rash, intraoral ulcer and endocarditis at the age
of 39 and had been on corticosteroids for 32 years
after a diagnosis of SLE had been made (average
Results3.2 mg/day). Physical examination disclosed a puls-
ating abdominal mass and computed tomography
Four of the five patients had received long-termshowed a pseudoaneurysm of the infrarenal aorta. At
corticosteroid administration for the treatment of SLEoperation, a haematoma was noted to be protruding
(mean 23, range 1–32 years). The average age of thefrom the disrupted aneurysmal wall. She recovered
patients with SLE was younger than that of the otheruneventfully.
patients without SLE (mean 55 vs. 77 years, p<0.05).
The sex ratio of our five cases showed a female dom-
inance (male/female – 2/3) compared with the control
group (male/female – 344/80; p<0.01). Following an-Case 4
eurysm repair, four patients continue to be followed
up at our institution without any sign of recurrentA 43-year-old woman presented with a pulsating mass
in her abdomen. She experienced Raynaud’s phe- aneurysm or other complications (mean 4.3, range
0.5–8.3 years).nomenon at the age of 18, endocarditis at 19 and
proteinuria at 21. Anti-double-strand DNA antibody The histopathologic features of the resected an-
eurysmal wall of the five patients with SLE are pre-and anti-nuclear antibody were both positive. She had
taken corticosteroid for 22 years (average 2.8 mg/ sented in Table 1. Intimal hypertrophy and medial
atrophy were common findings compared to the usualday). Renal biopsy had proved the diagnosis of lupus
nephritis. She underwent an uneventful replacement atherosclerotic AAA. On the contrary, the extensive
medial destruction in four cases, except for Case 2, wasof the infrarenal AAA.
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Fig. 1. (A) Angiogram in Case 5 revealed a 7.5-cm low thoraco-abdominal and a 4.5-cm infrarenal abdominal aortic aneurysm. At the
level of the renal arteries, the aortic diameter was normal. (B) Postoperative angiography two months after repair of the aneurysms.
Table 1. Histopathologic findings of aortic aneurysms in patients with SLE.
Case Intimal Foamy Destruction of Medial atrophy Adventitial fibrosis
hypertrophy macrophages medial elastic fibres
1 + + ++ + +
2 ++ ++ + ++ -
3 ++ + ++ ++ +
4 + + ++ ++ -
5 + + ++ (#) + +
Control group* ++ + + ++ +
-: absent; +: moderately present; ++: present over wide extensive zone.
#: Worm-eaten-like destruction was present.
*: summarised findings of five consecutive cases with atherosclerotic abdominal aortic aneurysm without SLE.
observed in the patients with SLE. Particularly note- companied by fibrinoid necrosis were observed, which
is reported to be the characteristic pathological featureworthy was the abnormal worm-eaten-like medial de-
struction widely observed in the aneurysmal wall of in organs of patients with SLE, such as kidney, adrenal
gland, digestive tract, spleen, bladder and lung. Micro-Case 5 (Fig. 2). No necrotic microvasculitic findings ac-
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Fig. 2. Medial atrophy with wide zone and severe degree of destruction of medial elastic fibres, together with abnormal worm-eaten-like
medial destruction are demonstrated in Case 5. (Elastic van Gieson stain, (A) ·40, (B) ·100.)
infarcts and marked vasculitis associated with gran- upper abdominal aorta and two in the infrarenal aorta.
ulation tissue formation suggesting primary arteritis In two cases, enlargement of the entire aorta was
were not present. noted. There were no reports of multiple aneurysms.
The type of aneurysm in the 16 reported cases consisted
of twelve dissecting aneurysms, three fusiform an-
eurysms and one pseudoaneurysm. Characteristically,Discussion
aortic dissections were well represented in the series
(12/16, 75%), and almost all cases with dissection wereDuring the past decade, we have experienced five
fatal except for three patients.15,18,21 In our series, onlypatients with AAAs who have previously been diag-
one case of acute aortic dissection was clinically diag-nosed as having SLE. To our knowledge, only 16
nosed two years after the initial aneurysmectomy. Thiscases of AA associated with SLE have been previously
predominance of aortic dissection accounts for thereported in the literature.7–22 The clinical features of
difference in clinical results of reported cases fromthese patients are given in Table 2.
those in our treated patients.The age of reported cases ranged from 28 to 65 years
As with our cases, the most common denominatorold (mean 40 years), which was also about 30 years
in the reported series was also long-term corticosteroidyounger than the mean age of our patients of AAA
therapy for SLE (range 1–22 years: mean 9 years).without SLE. The patients included seven males and
Adrenocorticosteroid administration has been re-nine females, and the female dominance, also present
cognised to be the main therapeutic option for SLE,in our series, may reflect the greater prevalence of this
the effects of which are well known, with inhibitionautoimmune condition in women. The location of the
of the formation of granulation tissue and chondroitinAAs varied: four in the ascending aorta, three in the
aortic arch, three in the descending aorta, two in the sulphate.23 Administration has improved the overall
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Table 2. Reported cases of aortic aneurysms associated with autoimmune disease.
Authors Type of Duration of steroid
(year of publication) Age/sex Location aneurysm Operability Survival therapy (years)
Bernhard7 (1969) 30/F Asc Dissection + Dead 4
Walts8 (1977) 34/M All Dissection - Dead 22
Okiye9 (1983) 33/M Des Dissection + Dead 6
Pazirandeh10 (1988) 36/F Arc Dissection - Dead 2.5
Kimura11 (1989) 38/F Arc Dissection - Dead 7
Seyama12 (1989) 54/M AAS Fusiform + Alive 1.5
Yoshimato13 (1989) 28/F All Dissection - Dead 11
Chakravarty14 (1992) 43/F Arc Fusiform + Alive 1
Dugo15 (1993) 29/F AAS Dissection - Alive 1
Stehbens16 (1993) 56/M AAI Saccular + Alive 16
Roger17 (1995) 31/F Asc Dissection - Dead 12
Ohge18 (1995) 55/F Asc Dissection + Alive 11
Sclair19 (1995) 30/F Des Dissection - Dead 13
Lam20 (1997) 65/M Des Dissection - Dead 1
Hussain21 (1998) 40/M Asc Dissection + Alive 22
Marubayashi22 (1998) 40/M AAI Fusiform + Alive 18
40.4–11.5 s.e.m. 9.2–7.7 s.e.m.
AAI: infrarenal abdominal aorta; AAS: suprarenal abdominal aorta; All: entire aorta; Arc: aortic arch; Asc: ascending aorta; Des: descending
aorta.
prognosis of these patients, but may result in de- (0/5) and hyperlipidaemia (0/5). The absence of nec-
rotic microvasculitis accompanied by fibrinoid nec-leterious effects on the cardiovascular system.24,25 Bul-
kley and Roberts reported an increased incidence of rosis may also reflect the effect of long-term steroid
therapy,6,24,26 although it weakens the medial elastichypertension, left-ventricular hypertrophy and athero-
sclerosis in patients with SLE treated with steroid for lamina.26
In conclusion, prolonged corticosteroid ad-over 1 year.26 It can accelerate atherosclerotic change
of the aortic wall, which is a well-noted complication ministration seems to play a major role in accelerating
atherosclerosis, which can result in aortic aneurysmalof patients with SLE. The contribution of cortico-
steroids to the development of aortic lesions in patients enlargement, possibly together with primary aortic-
wall involvement and/or vasculitic damage, par-with SLE has been difficult to assess, and there have
been no reports concerning aortic aneurysmal for- ticularly severe medial destruction, in patients with
SLE. However, the absence of fibrinoid necrosis, amation due to corticosteroid administration in patients
without SLE. characteristic finding in the organs of patients with
SLE, supports the causal link between the prolongedThere have been only a handful of reports describing
detailed findings of the aorta aneurysm histo- corticosteroid therapy and the aortic aneurysmal en-
largement.pathologically. Moreover, only one case report by
Stehben et al.16 gives a pathological description of a
non-dissecting aortic aneurysm associated with SLE.
They described the findings of thrombus with under-
lying atheromatous debris containing lipophages and References
remaining medial elastic fibres deep to the debris,
1 Oh WMC, Taylor RT, Olsen EGJ. Aortic regurgitation in sys-which also did not differ from the findings in patients
temic lupus erythematosus requiring aortic valve replacement.with atherosclerotic AAA without SLE. Moreover, the Br Heart J 1974; 36: 413–416.
2 Yetes DB, Scott JT. Cardiac valvular disease in chronic in-wide zone of medial destruction shown in our patients
flammatory disorders of connective tissue. Ann Rheum Dis 1975;with SLE was not reported in the paper by Stehben.
34: 321–325.Nashel reported that accelerated atherosclerosis was 3 MacLeod CB, Johnson D, Frable WJ. “Tree-barking” of the
ascending aorta. Am J Clin Pathol 1992; 97: 58–62.associated with long-term corticosteroid treatment, in
4 Shearer MA. Review: the heart in systemic lupus erythematosus.patients with rheumatoid arthritis.27 The histological
Am Heart J 1959; 58: 452–466.findings of our four patients on prolonged steroid 5 Bonfiglio TA, Botti RE, Hagstrom JWC. Coronary arteritis,
occlusion and myocardial infarction due to lupus erythematosus.therapy except for Case 2 demonstrated intimal athero-
Am Heart J 1972; 83: 153–158.sclerosis at a young age even though they had few
6 Cervera R, Font J, Pare C et al. Cardiac disease in systemicother risk factors, e.g. of smoking (1/5), hypertension lupus erythematosus: prospective study of 70 patients. Ann
Rheum Dis 1992; 51: 156–159.(1/5), ischaemic heart disease (0/5), diabetes mellitus
Eur J Vasc Endovasc Surg Vol 19, March 2000
Aortic Aneurysm with Systemic Lupus Erythematosus 293
7 Bernhard GC, Lange RL, Hensley GT. Aortic disease with dissecting complicating systemic lupus erythematosus. Pathology
1995; 27: 224–228.valvular insufficiency as the principal manifestation of systemic
18 Ohge H, Imai K, Shirage K et al. A case of surgical treatmentlupus erythematosus. Ann Intern Med 1969; 71: 81–87.
of acute aortic dissection without an intimal tear. J Jpn Assoc8 Walts AE, Dubois EL. Acute dissecting aneurysm of the aorta
Thorac Surg 1995; 46: 866–869.as the fatal event in systemic lupus erythematosus. Am Heart J
19 Sclair M, Nassar H, Bar-Ziv Y, Putterman C. Dissecting1977; 93: 378–381.
aortic aneurysm in systemic lupus erythematosus. Lupus 1995;9 Okie SE, Sterioff S, Schaff HV, Engen DE, Zincke H. Acute
4: 71–74.dissecting aneurysm of the aorta after renal transplantation. J
20 Lam KY, Cheung F, Yam LYC, Lee CH, Fung KH. AtypicalUrol 1983; 129: 803–804.
manifestations in a patient with systemic lupus erythematosus.10 Pazirandeh M, Ziran BH. Dissecting aortic aneurysm in a
J Clin Pathol 1997; 50: 174–176.patient with systemic lupus erythematosus. J Rheumatol 1988; 15:
21 Hussain KM, Chandna H, Santhanam V et al. Aortic dissection525–527.
in a young corticosteroid-treated patient with systemic lupus11 Kimura K, Maeta T, Shitomi K et al. A case of systemic lupus
erythematosus. Angiology 1998; 49: 649–652.erythematosus complicated with dissecting aortic aneurysm.
22 Marubayashi S, Sugi K, Ishiyama K et al. A case of abdominalNippon Naika Gakkai Zasshi 1989; 78: 591–592. aortic aneurysm associated with systemic lupus erythematosus.12 Seyama K, Muto J, Furuya H et al. A case of upper abdominal Hiroshima J Med Sci 1998; 47: 85–87.aortic aneurysm associated with systemic lupus erythematosus. 23 Lorenzen I. Corticosteroid and vascular connective tissue. Acta
Jin to Touseki 1989; 27: 1139–1144. Endocrinol 1969; 62: 67–76.
13 Yoshimoto K, Saima S, Nakamura Y et al. A case of acute 24 Bernhard GC, Lange RL, Hensley GT. Aortic disease with
dissecting aneurysm of the aorta in systemic lupus ery- valvular insufficiency as the principal manifestation of systemic
thematosus. Nippon Jinzo Gakkai Shi 1989; 31: 1211–1216. lupus erythematosus. Ann Intern Med 1969; 71: 81–87.
14 Chakravarty K, Scott DGI. Mycotic aneurysm of the aortic 25 Doherty NE, Siegel RJ. Cardiovascular manifestations of sys-
arch masquerading as systemic lupus erythematosus. Ann Rheum temic lupus erythematosus. Am Heart J 1985; 110: 1257–1265.
Dis 1992; 51: 1079–1081. 26 Bulkley BH, Roberts EL. The heart in systemic lupus ery-
15 Dugo M, Liessi G, De Luca M et al. Dissection of the thoracic- thematosus and the changes induced in it by corticosteroid
abdominal aorta in a young adult with systemic lupus ery- therapy. A study of 36 necropsy patients. Am J Med 1977; 58:
thematosus. Clin Nephrol 1993; 39: 349–351. 243–264.
16 Stehbens WE, Delahunt B, Shirer WC, Naik DK. Aortic 27 Nashel DJ. Is atherosclerosis a complication of long-term cortico-
steroid treatment? Am J Med 1986; 80: 925–929.aneurysm in systemic lupus erythematosus. Histopathology 1993;
22: 275–277.
17 Guard RW, Graham IG, Edmonds JP, Thomas AC. Aortitis with Accepted 1 July 1999
Eur J Vasc Endovasc Surg Vol 19, March 2000
